Lattice Biologics Ltd.

10:33 AM EST - Lattice Biologics Ltd. : Has obtained TSX Venture Exchange approval to issue 75,115 common shares of the Company to an individual as compensation for certain services rendered to the Company during January and February of 2017. The shares will be issued pursuant to the terms of the Shares for Services Agreement (announced August 8, 2016) at a deemed price of $0.214. Lattice Biologics Ltd. shares (V.LBL) are trading up $0.01 at $0.25.